July 13, 2023, 1:07 p.m. | Ingrid Lunden

TechCrunch techcrunch.com

Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery. Today, another hopeful in the space is announcing a funding round to expand its own contribution to the field. Causaly, a London startup that has built an AI platform to help researchers […]


Causaly, an AI platform for drug discovery and biomedical research, raises $60M by Ingrid Lunden originally published on TechCrunch

ai ai drug discovery ai platform artificial artificial intelligence big biomedical biotech & health causaly discovery drug discovery funding funding round health iconiq growth index ventures intelligence london medical medical research platform raises research space startup world

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US

Research Engineer

@ Allora Labs | Remote

Ecosystem Manager

@ Allora Labs | Remote

Founding AI Engineer, Agents

@ Occam AI | New York

AI Engineer Intern, Agents

@ Occam AI | US